Revvity, NEV11070, IVISense Hypoxia CA IX 680 Fluorescent Probe (HypoxySense)

Overview
In cancer, hypoxia occurs in tumors as a result of the poor ability of their disorganized vascular networks to deliver blood borne oxygen. IVISense Hypoxia CA IX 680 fluorescent imaging probe detects the tumor cell surface expression of carbonic anhydrase 9 (CA IX) protein, which increases in hypoxic regions within many tumors, especially in cervical, colorectal, non-small cell lung tumors. Pairing IVISense Hypoxia CA IX 680 agent with optical fluorescent imaging technology allows you to image and quantitate tumor sub-regions undergoing hypoxia-related changes, non-invasively and in vivo. Brand-IVISense
Fluorescent Agent Type-Targeted
Imaging Modality-Fluorescence
Shipping Conditions-Shipped in Blue Ice
Specificity-Carbonic Anhydrase IX
Storage Conditions-+2 to +8 °C
Therapeutic Area-Angiogenesis Arthritis Oncology
Unit Size-1 vial (10 doses)
Wave Length-680 nm